CLINICAL DENTISTRY GUIDELINES
F. Interim caries arresting medicament application (Code D1354) Silver Diamine Fluoride (SDF) is an interim caries
arresting liquid medicament clinically applied to control and prevent the further progression of active dental caries,
and reduce dental hypersensitivity. Treatment with Silver Diamine Fluoride will not eliminate the need for
restorative dentistry to repair function or aesthetics, but this alternative treatment allows oral health care
professionals to temporarily arrest caries with noninvasive methods, particularly with young children that have
primary teeth. This should be submitted on a per tooth basis.
RESTORATIVE TREATMENT
A. Restorative procedures for teeth exhibiting a poor prognosis due to gross carious destruction of the clinical crown
at/or below the bone level, advanced periodontal disease, untreated periapical pathology or poor restorability are
not covered. (MMPROG_) (MMPROGR)
B. Amalgam Restorations (Codes D2140‐D2161)
1
. Dental amalgam is a cavity‐filling material made by combining mercury with other metals such as silver, copper
and tin. Numerous scientific studies conducted over the past several decades, including two large clinical trials
published in the April 2006 Journal of the American Medical Association, indicate dental amalgam is a safe,
effective cavity‐filling material for children and others. And, in its 2009 review of the scientific literature on
amalgam safety, the ADA's Council on Scientific Affairs reaffirmed that the scientific evidence continues to
support amalgam as a valuable, viable and safe choice for dental patients…”
2
. On July 28, 2009, the American Dental Association (ADA) agreed with the U.S. Food and Drug Administration's
(FDA) decision not to place any restriction on the use of dental amalgam, a commonly used cavity filling
material:
a. The procedures of choice for treating caries or the replacement of an existing restoration not involving or
undermining the cusps of posterior teeth is generally amalgam or composite.
b. Facial or buccal restorations are generally considered to be “one surface” restorations, not three surfaces
such as MFD or MBD. (MMMOD)
c. The replacement of clinically acceptable amalgam fillings with an alternative material (composite, crown,
etc.) is considered cosmetic and is not covered unless decay or fracture of the existing filling is present.
(MMTRT)
d. If a dentist chooses not to provide amalgam fillings, alternative posterior fillings must be made available for
LIBERTY patients. Any listed amalgam copayments would still apply.
e. An amalgam restoration includes tooth preparation and all adhesives, liners and bases. (MMINC)
f. An amalgam restoration may be medically necessary when a tooth has a fracture, defective filling or decay
penetrating into the dentin. (MM214)
g. An amalgam restoration should have sound margins, appropriate occlusion and contacts and must treat all
decay that is evident. (MM241)
C. Resin‐based Composite Restorations (Codes D2330 – D2394)
1
. The procedures of choice for treating caries or the replacement of an existing restoration not involving or
undermining the incisal edges of an anterior tooth is composite. Decay limited to the incisal edge only, may still
be a candidate for a filling restoration if little to no other surfaces manifest caries or breakdown.
. Facial or buccal restorations are generally considered to be “one surface” restorations, not three surfaces such
as MFD or MBD. (MMMOD)
. The replacement of clinically acceptable amalgam fillings with alternative materials (composite, crown, etc.) is
considered cosmetic and is not covered unless decay or fracture is present. (MMTRT)
. A resin‐based composite restoration includes tooth preparation, acid etching, adhesives, liners, bases and
curing. (MMINC)
. A resin‐based composite restoration may be medically necessary when a tooth has a fracture, defective filling,
recurrent decay or decay penetrating into the dentin. (MM230) (MM231)
. A composite restoration should have sound margins, appropriate occlusion and contacts and must treat all
decay that is evident. (MM232)
2
3
4
5
6
Clinical Criteria Guidelines v.20180109
Page 7 of 22